Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-12

Clinical Trial Update: Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic/pharmacodynamic study evaluating three subcutaneous single-dose formulations of epoetin alfa in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Bio Sidus SA | Conditions: Anemia | Phase 1 | Status: COMPLETED | Results posted: 2020-02-12